content_top
43 companies, 1 interpreter! Insight, foresight
and recommendation 

Aduro Biotech Inc. (ADRO)

11.15
-0.50
(-4.29%)
Sep 11, 4:00PM EDT
content_middle

Aduro Biotech Inc. (NASDAQ: ADRO) is a clinical stage immuno-oncology company developing cancer therapies. Shares priced at $17 last Wednesday, above the expected range $14 to $16. The biotech firm is the first health care company in more than 10 years with a market cap above $1 billion to double on its first day of trading. The stock closed its first day of trading up 147%, and it closed the week at $40.00, up 135.3%.

Previous Close: 
11.65
Open: 
11.70
Bid: 
11.15
Ask: 
11.20
1yr Target Price: 
18.25
Day's Range: 
11.05 - 11.90
52wk Range: 
8.75 - 15.52
Volume: 
461256
Average Daily Volume: 
356934
Market Capitalization: 
831.92M
Trailing Annual Dividend Yield: 
N/A
Shares Outstanding: 
74612000M